Biora Therapeutics Announces Completion Of Multiple-Ascending Dose Cohorts For Clinical Trial Of BT-600
Dosing of all patients in the trial has been successfully completed Final results are expected to be available in late Q2 2024SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (NASDAQ:BIOR), the